Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-021699

Chief Financial Officer sold 1,827 shares at $9.17 ($16,754)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Koppikar Utpal Chief Financial Officer 2020-03-27 Sale −1,827 $9.17 $16,754 137,330 D
Open-market sales · 1,827 sh · avg $9.17 · $16,754
Loading xslF345X03/doc4.xml…